SNDX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SNDX Shares Outstanding History and SNDX YTD Return |
SNDX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SNDX Shares Outstanding History and SNDX YTD Return |
SNDX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+32.02% CAGR Mouse over chart for data details
|
SNDX Stock Price Chart |
About Syndax Pharmaceuticals Inc |
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of cancer therapies. Co.'s two primary product candidates are, revumenib (SNDX-5613), and axatilimab (SNDX-6352). Co. is developing SNDX-5613, a small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia, and acute myeloid leukemia, or AML, and NPM1 mutant AML. Co. is also developing SNDX-6352, a monoclonal antibody that blocks the colony stimulating factor 1, in chronic graft-versus-host disease, as well as idiopathic pulmonary fibrosis. We show 34 historical shares outstanding datapoints in our SNDX shares outstanding history coverage, used to compute SNDX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SNDX market cap history over the course of time is important for investors interested in comparing SNDX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SNDX versus a peer is one thing; comparing SNDX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SNDX can fluctuate over the course of history. With this page we aim to empower investors researching SNDX by allowing them to research the SNDX market cap history. |
SNDX Current Stock Quote |
Free SNDX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SNDX Share Performance |
Market Cap Peers |
Syndax Pharmaceuticals (SNDX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SNGX Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.